• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对万古霉素敏感性降低的金黄色葡萄球菌——伊利诺伊州,1999年

Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.

出版信息

MMWR Morb Mortal Wkly Rep. 2000 Jan 7;48(51-52):1165-7.

PMID:11266244
Abstract

Staphylococcus aureus is one of the most common causes of hospital- and community-acquired infections. Nosocomial methicillin-resistant S. aureus (MRSA) infections have become common, and cases of community-acquired MRSA infections also have occurred. Since 1996, vancomycin-intermediate S. aureus (VISA; vancomycin minimum inhibitory concentration [MIC = 8-16 microg/mL) has been identified in Europe, Asia, and the United States. The emergence of reduced vancomycin susceptibility in S. aureus increases the possibility that some strains will become fully resistant and that available antimicrobial agents will become ineffective for treating infections caused by such strains. This report describes the fourth case of confirmed VISA from a patient in the United States.

摘要

金黄色葡萄球菌是医院获得性感染和社区获得性感染最常见的病因之一。医院内耐甲氧西林金黄色葡萄球菌(MRSA)感染已很常见,社区获得性MRSA感染病例也有发生。自1996年以来,在欧洲、亚洲和美国已发现万古霉素中介金黄色葡萄球菌(VISA;万古霉素最低抑菌浓度[MIC]=8 - 16微克/毫升)。金黄色葡萄球菌对万古霉素敏感性降低的出现增加了某些菌株完全耐药以及现有抗菌药物对治疗由此类菌株引起的感染变得无效的可能性。本报告描述了美国一名患者确诊的第四例VISA病例。

相似文献

1
Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.对万古霉素敏感性降低的金黄色葡萄球菌——伊利诺伊州,1999年
MMWR Morb Mortal Wkly Rep. 2000 Jan 7;48(51-52):1165-7.
2
Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.对万古霉素敏感性降低的金黄色葡萄球菌——美国,1997年
MMWR Morb Mortal Wkly Rep. 1997 Aug 22;46(33):765-6.
3
Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.最新消息:对万古霉素敏感性降低的金黄色葡萄球菌——美国,1997年
MMWR Morb Mortal Wkly Rep. 1997 Sep 5;46(35):813-5.
4
Staphylococcus aureus resistant to vancomycin--United States, 2002.2002年美国出现对万古霉素耐药的金黄色葡萄球菌
MMWR Morb Mortal Wkly Rep. 2002 Jul 5;51(26):565-7.
5
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).耐甲氧西林金黄色葡萄球菌(MRSA)中糖肽类药物敏感性降低。
Int J Antimicrob Agents. 2007 Nov;30(5):398-408. doi: 10.1016/j.ijantimicag.2007.07.011. Epub 2007 Sep 20.
6
Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.1996年日本金黄色葡萄球菌对万古霉素的敏感性降低
MMWR Morb Mortal Wkly Rep. 1997 Jul 11;46(27):624-6.
7
MRSA--the tip of the iceberg.耐甲氧西林金黄色葡萄球菌——冰山一角。
Clin Microbiol Infect. 2006 Apr;12 Suppl 2:3-10. doi: 10.1111/j.1469-0691.2006.01402.x.
8
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.万古霉素最低抑菌浓度对耐甲氧西林金黄色葡萄球菌菌血症治疗的影响
Clin Infect Dis. 2008 Jan 15;46(2):193-200. doi: 10.1086/524667.
9
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.金黄色葡萄球菌中万古霉素耐药性的出现。糖肽类中介金黄色葡萄球菌工作组。
N Engl J Med. 1999 Feb 18;340(7):493-501. doi: 10.1056/NEJM199902183400701.
10
Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.1997 - 2001年美国耐万古霉素金黄色葡萄球菌感染的流行病学和微生物学特征
Clin Infect Dis. 2003 Feb 15;36(4):429-39. doi: 10.1086/346207. Epub 2003 Jan 31.

引用本文的文献

1
In vitro susceptibility to methicillin, vancomycin and linezolid of staphylococci isolated from bloodstream infections in eastern Turkey.从土耳其东部血流感染中分离出的葡萄球菌对甲氧西林、万古霉素和利奈唑胺的体外敏感性
Braz J Microbiol. 2014 Oct 9;45(3):829-33. doi: 10.1590/s1517-83822014000300010. eCollection 2014.
2
The usefulness of arbekacin compared to vancomycin.阿贝卡星相对于万古霉素的有用性。
Eur J Clin Microbiol Infect Dis. 2012 Jul;31(7):1663-6. doi: 10.1007/s10096-011-1490-9. Epub 2011 Nov 29.
3
Antibiotic prophylaxis in the management of vesicoureteral reflux.
膀胱输尿管反流管理中的抗生素预防
Adv Urol. 2008;2008:825475. doi: 10.1155/2008/825475.
4
Clinical outcome with oral linezolid and rifampin following recurrent methicillin-resistant Staphylococcus aureus bacteremia despite prolonged vancomycin treatment.尽管长期使用万古霉素治疗,耐甲氧西林金黄色葡萄球菌复发性菌血症患者口服利奈唑胺和利福平后的临床结局
Can J Infect Dis. 2004 Mar;15(2):97-100. doi: 10.1155/2004/768765.
5
VISA, hetero-VISA and VRSA: the end of the vancomycin era?万古霉素中介金黄色葡萄球菌、异质性万古霉素中介金黄色葡萄球菌及耐万古霉素金黄色葡萄球菌:万古霉素时代的终结?
Can J Infect Dis. 2002 Sep;13(5):282-4. doi: 10.1155/2002/245109.
6
Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.印度北部一家三级护理医院出现耐万古霉素金黄色葡萄球菌(VRSA)。
BMC Infect Dis. 2006 Oct 26;6:156. doi: 10.1186/1471-2334-6-156.
7
Antibiotic management of ventilator-associated pneumonia due to antibiotic-resistant gram-positive bacterial infection.耐抗生素革兰氏阳性菌感染所致呼吸机相关性肺炎的抗生素管理
Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):794-803. doi: 10.1007/s10096-005-0053-3.
8
Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II.对糖肽类药物敏感性降低的金黄色葡萄球菌分离株属于辅助基因调节子I组或II组。
Antimicrob Agents Chemother. 2004 Mar;48(3):1024-7. doi: 10.1128/AAC.48.3.1024-1027.2004.
9
Staphylococcus aureus with heterogeneous resistance to vancomycin: epidemiology, clinical significance, and critical assessment of diagnostic methods.对万古霉素具有异质性耐药的金黄色葡萄球菌:流行病学、临床意义及诊断方法的批判性评估
Antimicrob Agents Chemother. 2003 Oct;47(10):3040-5. doi: 10.1128/AAC.47.10.3040-3045.2003.
10
Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin.对临床耐万古霉素金黄色葡萄球菌分离株的微阵列转录分析。
J Bacteriol. 2003 Aug;185(15):4638-43. doi: 10.1128/JB.185.15.4638-4643.2003.